Company / Total Assets
Tarsus Pharmaceuticals, Inc. Total Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$562.2M
FY2025
5-year range
$178.9M / $562.2M
FY2021-FY2025
Trend
+49.1%
vs FY2024
Sector context
#129 of 214
Health Care
What the data says
At $562M, Tarsus Pharmaceuticals, Inc.'s total assets ranks #129 of 214 in the Health Care sector. Total Assets has increased for 6 consecutive years, from $58M in FY2019 to $562M in FY2025.
Based on SEC 10-K filings.
$562M in FY2025 with a 5-year CAGR of +26.7%.
Improved from $265M to $562M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +35.1%
- 5-Year CAGR
- +26.7%
- 10-Year CAGR
- -
Sector benchmark
#129 of 214 in Health CareTop 60% of 214This company $562.2M Sector average $7.5B
▼
-92.5% below sector average
Key checks
Key Insights
- Tarsus Pharmaceuticals, Inc.'s total assets has grown for 6 consecutive years.
- 5-year CAGR of +26.7%, indicating consistent growth.
- In FY2025, total assets increased 49.1% year-over-year.
- Ranks #129 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $562.2M | +49.1% |
| FY2024 | $377.0M | +42.0% |
| FY2023 | $265.5M | +16.5% |
| FY2022 | $227.9M | +27.4% |
| FY2021 | $178.9M | +4.0% |
| FY2020 | $172.0M | +194.9% |
| FY2019 | $58.3M | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026